David C. Lamb

12.5k total citations
120 papers, 5.4k citations indexed

About

David C. Lamb is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, David C. Lamb has authored 120 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 62 papers in Pharmacology and 40 papers in Pharmacology. Recurrent topics in David C. Lamb's work include Pharmacogenetics and Drug Metabolism (61 papers), Microbial Natural Products and Biosynthesis (33 papers) and Steroid Chemistry and Biochemistry (24 papers). David C. Lamb is often cited by papers focused on Pharmacogenetics and Drug Metabolism (61 papers), Microbial Natural Products and Biosynthesis (33 papers) and Steroid Chemistry and Biochemistry (24 papers). David C. Lamb collaborates with scholars based in United Kingdom, United States and Germany. David C. Lamb's co-authors include Steven L. Kelly, Diane Kelly, Michael R. Waterman, Brian C. Baldwin, N. J. Manning, Andrew J. Corran, Andrew G. S. Warrilow, F. Peter Guengerich, Bin Zhao and Colin J. Jackson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

David C. Lamb

114 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Lamb United Kingdom 43 2.5k 1.6k 1.4k 1.4k 1.1k 120 5.4k
Steven L. Kelly United Kingdom 58 3.6k 1.4× 3.8k 2.4× 2.1k 1.4× 1.6k 1.1× 2.8k 2.5× 246 10.1k
Larissa M. Podust United States 42 2.2k 0.9× 555 0.4× 886 0.6× 1.4k 1.0× 685 0.6× 76 4.2k
Galina I. Lepesheva United States 39 1.4k 0.6× 714 0.5× 542 0.4× 631 0.4× 1.6k 1.4× 85 4.1k
Luc Koymans Belgium 19 1.5k 0.6× 1.1k 0.7× 413 0.3× 1.9k 1.3× 622 0.6× 30 4.5k
James J. De Voss Australia 39 2.8k 1.1× 482 0.3× 744 0.5× 1.8k 1.3× 332 0.3× 194 5.7k
James B. McMahon United States 55 4.4k 1.8× 1.7k 1.1× 1.1k 0.8× 498 0.3× 819 0.8× 177 9.5k
W. David Nes United States 43 3.8k 1.5× 628 0.4× 1.1k 0.8× 353 0.2× 997 0.9× 196 6.3k
Po‐Huang Liang Taiwan 49 3.7k 1.5× 1.8k 1.1× 844 0.6× 423 0.3× 289 0.3× 135 6.7k
Hiroshi Tomoda Japan 48 4.8k 1.9× 513 0.3× 3.6k 2.6× 560 0.4× 390 0.4× 406 9.6k
H. Vanden Bossche Belgium 39 1.1k 0.5× 2.0k 1.3× 597 0.4× 472 0.3× 1.6k 1.5× 65 4.2k

Countries citing papers authored by David C. Lamb

Since Specialization
Citations

This map shows the geographic impact of David C. Lamb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Lamb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Lamb more than expected).

Fields of papers citing papers by David C. Lamb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Lamb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Lamb. The network helps show where David C. Lamb may publish in the future.

Co-authorship network of co-authors of David C. Lamb

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Lamb. A scholar is included among the top collaborators of David C. Lamb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Lamb. David C. Lamb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamb, David C., et al.. (2025). Crystal structure of cytochrome P450 NysL and the structural basis for stereo- and regio-selective oxidation of antifungal macrolides. Journal of Biological Chemistry. 301(3). 108185–108185.
2.
Hasan, Md. Mahbub, Melanie Clifford, Godwin A. Aleku, et al.. (2025). New Generation Modified Azole Antifungals against Multidrug-Resistant Candida auris. Journal of Medicinal Chemistry. 68(13). 14054–14071.
3.
Lamb, David C., Jared V. Goldstone, Julien Andréani, et al.. (2025). Cytochrome b5 occurrence in giant and other viruses belonging to the phylum Nucleocytoviricota. PubMed. 3(1). 8–8. 1 indexed citations
4.
Lamb, David C., et al.. (2025). Structure–Function Analysis of the Self-Sufficient CYP102 Family Provides New Insights into Their Biochemistry. International Journal of Molecular Sciences. 26(5). 2161–2161. 2 indexed citations
5.
Muldoon, Jimmy, Paul Evans, Y. Ortin, et al.. (2024). Biosynthesis of a new skyllamycin in Streptomyces nodosus: a cytochrome P450 forms an epoxide in the cinnamoyl chain. Organic & Biomolecular Chemistry. 22(14). 2835–2843. 1 indexed citations
6.
Robinson, William E., Claire Price, Steven L. Kelly, et al.. (2024). Vertebrate endocrine disruptors induce sex-reversal in blue mussels. Scientific Reports. 14(1). 23890–23890. 1 indexed citations
7.
Lamb, David C., et al.. (2023). Structure–Function Analysis of the Biotechnologically Important Cytochrome P450 107 (CYP107) Enzyme Family. Biomolecules. 13(12). 1733–1733. 7 indexed citations
8.
Aherfi, Sarah, Lucile Pinault, Jean‐Pierre Baudoin, et al.. (2021). Incomplete tricarboxylic acid cycle and proton gradient in Pandoravirus massiliensis : is it still a virus?. The ISME Journal. 16(3). 695–704. 17 indexed citations
9.
Goldstone, Jared V., Munirathinam Sundaramoorthy, Bin Zhao, et al.. (2015). Genetic and structural analyses of cytochrome P450 hydroxylases in sex hormone biosynthesis: Sequential origin and subsequent coevolution. Molecular Phylogenetics and Evolution. 94(Pt B). 676–687. 40 indexed citations
10.
Castellano, Sabrina, Cristina Sgherri, Mike Frank Quartacci, et al.. (2013). Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans. Journal of Antimicrobial Chemotherapy. 68(5). 1111–1119. 16 indexed citations
11.
Weynberg, Karen D., John Love, Michail N. Isupov, et al.. (2013). Functional and structural characterisation of a viral cytochrome b5. FEBS Letters. 587(22). 3633–3639. 7 indexed citations
12.
Regina, Giuseppe La, Felicia Diodata D’Auria, Andrea Tafi, et al.. (2008). 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, New Imidazoles with Potent Activity againstCandida albicansand Dermatophytes. Synthesis, Structure−Activity Relationship, and Molecular Modeling Studies. Journal of Medicinal Chemistry. 51(13). 3841–3855. 29 indexed citations
13.
Lamb, David C., Diane Kelly, Brian C. Baldwin, et al.. (2006). Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers. FEMS Microbiology Letters. 149(1). 25–30. 19 indexed citations
14.
Lamb, David C., Diane Kelly, N. J. Manning, & Steven L. Kelly. (2006). Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. FEMS Microbiology Letters. 147(2). 189–193. 6 indexed citations
15.
Kelly, Steven L., David C. Lamb, Colin J. Jackson, Andrew G. S. Warrilow, & Diane Kelly. (2003). The biodiversity of microbial cytochromes P450. Advances in microbial physiology. 47. 131–186. 57 indexed citations
16.
Lamb, David C., Haruo Ikeda, David R. Nelson, et al.. (2003). Cytochrome P450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2). Biochemical and Biophysical Research Communications. 307(3). 610–619. 85 indexed citations
17.
Kelly, Steven L., et al.. (1999). The G464S Amino Acid Substitution in Candida albicans Sterol 14α-Demethylase Causes Fluconazole Resistance in the Clinic through Reduced Affinity. Biochemical and Biophysical Research Communications. 262(1). 174–179. 91 indexed citations
18.
Lamb, David C., et al.. (1999). Purification and Characterization of a Benzo[a]pyrene Hydroxylase from Pleurotus pulmonarius. Biochemical and Biophysical Research Communications. 266(2). 326–329. 11 indexed citations
19.
Lamb, David C., Diane Kelly, N. J. Manning, & Steven Kelly. (1998). A sterol biosynthetic pathway in Mycobacterium. FEBS Letters. 437(1-2). 142–144. 50 indexed citations
20.
Lamb, David C.. (1997). Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. FEMS Microbiology Letters. 147(2). 189–193. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026